Cargando…
Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox – An animal model of smallpox
The human population is currently faced with the potential use of natural or recombinant variola and monkeypox viruses as biological weapons. Furthermore, the emergence of human monkeypox in Africa and its expanding environs poses a significant natural threat. Such occurrences would require therapeu...
Autores principales: | Parker, Scott, Chen, Nanhai G., Foster, Scott, Hartzler, Hollyce, Hembrador, Ed, Hruby, Dennis, Jordan, Robert, Lanier, Randall, Painter, George, Painter, Wesley, Sagartz, John E., Schriewer, Jill, Mark Buller, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722602/ https://www.ncbi.nlm.nih.gov/pubmed/22381921 http://dx.doi.org/10.1016/j.antiviral.2012.02.005 |
Ejemplares similares
-
Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus
por: Parker, Scott, et al.
Publicado: (2014) -
Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies
por: Parker, Scott, et al.
Publicado: (2009) -
Efficacy of therapeutic intervention with an oral ether–lipid analogue of cidofovir (CMX001) in a lethal mousepox model
por: Parker, Scott, et al.
Publicado: (2008) -
The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak
por: Foster, Scott A., et al.
Publicado: (2017) -
Ectromelia Virus Infections of Mice as a Model to Support the Licensure of Anti-Orthopoxvirus Therapeutics
por: Parker, Scott, et al.
Publicado: (2010)